论文部分内容阅读
目的:对布地奈德雾化吸入治疗小儿肺炎的临床疗效及安全性进行研究和判定。方法:我院将2014年1月至2015年2月收治的40例肺炎患儿进行随机分组为观察组与对照组,两组各20例患儿,对照组给予抗感染、止咳化痰等传统治疗,观察组在传统治疗基础上给予布地奈德雾化吸入治疗,并观察两组肺炎患儿的疾病体征消失天数及不良反应症状。结果:两组肺炎患儿均未出现不良反应,其中观察组疾病体征消失天数优于对照组,P<0.05。结论:给予肺炎患儿在传统治疗的基础上进行布地奈德雾化吸入途径给药的效果可观。
OBJECTIVE: To study and evaluate the clinical efficacy and safety of inhaled budesonide in children with pneumonia. Methods: Forty children with pneumonia admitted from January 2014 to February 2015 were randomly divided into observation group and control group. 20 children in each group were given anti-infection and cough-resolving phlegm The treatment group and the observation group were given budesonide inhalation therapy on the basis of the traditional treatment, and the number of days of symptom disappearance and adverse reaction symptoms in two groups of children with pneumonia were observed. Results: There were no adverse reactions in both groups of children with pneumonia. The days of disappearance of symptoms in the observation group were better than those in the control group (P <0.05). CONCLUSIONS: The administration of budesonide inhalation route to children with pneumonia is effective on the basis of traditional treatment.